Picking out patients whose cancers have high-risk genetic features could help clinicians realise sooner if they’re unlikely to respond to treatment, enabling them to find alternative options as early as possible.
Read More
The drug is the first licensed treatment available on the NHS in the UK to treat this condition.
Read More
The discovery could be the answer to why some people are more likely to develop a devastating lung disease – idiopathic pulmonary fibrosis (IPF).
Read More
Since 2015, the first-of-its-kind collaboration has brought together academic and pharmaceutical industry researchers to create a deeper understanding of how HIV works.
Read More
The novel mammography imaging system could potentially “spell an end” to unnecessary biopsies, by determining benign or malignant breast lesions.
Read More
